AUTHOR=Nicolescu Ramona C. , Al-Khawaga Sara , Minassian Berge A. , Hussain Khalid 

TITLE=Diabetes Mellitus in a Patient With Lafora Disease: Possible Links With Pancreatic β-Cell Dysfunction and Insulin Resistance

JOURNAL=Frontiers in Pediatrics

VOLUME=6

YEAR=2019

URL=https://www.frontiersin.org/journals/pediatrics/articles/10.3389/fped.2018.00424

DOI=10.3389/fped.2018.00424

ISSN=2296-2360

ABSTRACT=<p>Lafora disease (LD) is a rare autosomal recessive disorder characterized by progressive myoclonic epilepsy followed by continuous neurological decline, culminating in death within 10 years. LD leads to accumulation of insoluble, abnormal, glycogen–like structures called Lafora bodies (LBs). It is caused by mutations in the gene encoding glycogen phosphatase (<italic>EPM2A)</italic> or the E3 ubiquitin ligase malin (<italic>EPM2B/NHLRC1)</italic>. These two proteins are involved in an intricate, however, incompletely elucidated pathway governing glycogen metabolism. The formation of EPM2A and malin signaling complex promotes the ubiquitination of proteins participating in glycogen metabolism, where dysfunctional mutations lead to the formation of LBs. Herein, we describe a 13-years-old child with LD due to a <italic>NHLRC1</italic> (c.386C &gt; A, p.Pro129His) mutation, who has developed diabetes mellitus and was treated with metformin. We discuss how basic mechanisms of LD could be linked to β-cell dysfunction and insulin resistance.</p>